We are live on ! Find out more
ACM

ACT Capital Management Portfolio holdings

AUM $153M
This Fund
S&P 500
This Quarter Est. Return
+20.59%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$195M
AUM Growth
–
Cap. Flow
+$180M
Cap. Flow %
92.65%
Top 10 Hldgs %
56.76%
Holding
117
New
116
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
STAA icon
STAAR Surgical
STAA
+$30.5M
2
ARWR icon
Arrowhead Research
ARWR
+$15.5M
3
ARCT icon
Arcturus Therapeutics
ARCT
+$15.4M
4
CLSD
Clearside Biomedical
CLSD
+$7.63M
5
AWH
Aspira Women's Health Inc. Common Stock
AWH
+$6.48M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 79.63%
2 Technology 6.05%
3 Communication Services 5.12%
4 Financials 3.37%
5 Consumer Staples 1.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IMTX icon
51
Immatics
IMTX
$1.34B
$738K 0.38%
+63,500
New +$745K
ENLV icon
52
Enlivex Ltd
ENLV
$36.7M
$735K 0.38%
+5,500
New +$827K
NVDA icon
53
NVIDIA
NVDA
$5.31T
$721K 0.37%
+36,000
New +$577K
GMBL
54
DELISTED
Esports Entertainment Group Inc. Common Stock
GMBL
$706K 0.36%
+2
New +$942K
AMZN icon
55
Amazon
AMZN
$2.94T
$689K 0.35%
+4,000
New +$665K
COIN icon
56
Coinbase
COIN
$39.5B
$684K 0.35%
+2,700
New +$701K
CRDF icon
57
Cardiff Oncology
CRDF
$74.3M
$682K 0.35%
+102,500
New +$869K
CRIS icon
58
Curis
CRIS
$8.85M
$646K 0.33%
+200
New +$904K
RYTM icon
59
Rhythm Pharmaceuticals
RYTM
$7.59B
$607K 0.31%
+31,000
New +$644K
CKPT
60
DELISTED
Checkpoint Therapeutics
CKPT
$605K 0.31%
+20,500
New +$568K
PDSB icon
61
PDS Biotechnology
PDSB
$40.6M
$565K 0.29%
+45,000
New +$351K
TDC icon
62
Teradata
TDC
$2.47B
$550K 0.28%
+11,000
New +$500K
OYST
63
DELISTED
Oyster Point Pharma, Inc. Common Stock
OYST
$542K 0.28%
+31,500
New +$599K
FBRX icon
64
Forte Biosciences
FBRX
$1.57B
$541K 0.28%
+643
New +$579K
CELL
65
DELISTED
PhenomeX Inc. Common Stock
CELL
$538K 0.28%
+12,000
New +$556K
CSBR icon
66
Champions Oncology
CSBR
$73.6M
$514K 0.26%
+50,000
New +$507K
SIOX
67
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
$506K 0.26%
+185,000
New +$460K
AMPE
68
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
$487K 0.25%
+972
New +$522K
JMIA
69
Jumia Technologies
JMIA
$727M
$440K 0.23%
+14,500
New +$439K
AUD
70
DELISTED
Audacy, Inc.
AUD
$421K 0.22%
+97,500
New +$448K
RKT icon
71
Rocket Companies
RKT
$39.2B
$420K 0.22%
+21,700
New +$439K
HLMN icon
72
Hillman Solutions
HLMN
$1.81B
$403K 0.21%
+32,500
New +$362K
ORIO
73
Orion Digital Corp
ORIO
$15.6M
$373K 0.19%
+15,833
New +$379K
AFRM icon
74
Affirm
AFRM
$26.3B
$337K 0.17%
+5,000
New +$319K
ARQT icon
75
Arcutis Biotherapeutics
ARQT
$3.39B
$328K 0.17%
+12,000
New +$338K
1 2
3
4 5

Similar funds

BCI
Blue Capital Inc Omaha, Nebraska $153M AUM 28.69% 1-Year Est. Return
APW
Atlantic Private Wealth Chapel Hill, North Carolina $153M AUM 15.75% 1-Year Est. Return
DAM
Doheny Asset Management Los Angeles, California $153M AUM 42.04% 1-Year Est. Return
BVC
Bright Valley Capital Hong Kong $153M AUM 16.24% 1-Year Est. Return
RHAM
Round Hill Asset Management Pasadena, California $153M AUM 6.67% 1-Year Est. Return
RFN
Redwood Financial Network Solon, Ohio $153M AUM 17.17% 1-Year Est. Return
SGM
Sellaronda Global Management New York $152M AUM 2.1% 1-Year Est. Return
HWM
Horizons Wealth Management Asheville, North Carolina $152M AUM 9.43% 1-Year Est. Return

ACT Capital Management's Q2 2021 Portfolio in Review

Q2 2021 is the first quarter with a 13F filing on record for ACT Capital Management, which disclosed 117 positions worth $195M. Its ten largest holdings account for 57% of the portfolio.

Its largest position is STAAR Surgical: 231,600 shares worth $35.3M.

By sector, the portfolio is most concentrated in Healthcare at 80% of assets, followed by Technology and Communication Services.

  • ACT Capital Management's largest Q2 2021 buy was STAAR Surgical: 231,600 shares worth $35.3M.
  • ACT Capital Management's ten largest holdings make up 57% of its $195M portfolio in Q2 2021.
  • ACT Capital Management disclosed 117 positions in Q2 2021, its first 13F filing on record.

Based on ACT Capital Management's 13F filing for Q2 2021, filed 16 Aug 2021.